BBBT — Black Bird Biotech Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $0.73m
- $0.08m
Annual cashflow statement for Black Bird Biotech, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.121 | -0.122 | -0.69 | -1.81 | -1.66 |
| Depreciation | |||||
| Non-Cash Items | — | — | 0.058 | 0.84 | 0.37 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.045 | 0.036 | 0.013 | -0.131 | 0.167 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | -0.076 | -0.086 | -0.619 | -0.992 | -1.03 |
| Capital Expenditures | — | — | -0.02 | -0.186 | 0 |
| Purchase of Fixed Assets | |||||
| Cash from Investing Activities | — | — | -0.02 | -0.186 | 0 |
| Financing Cash Flow Items | — | — | -0.008 | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.079 | 0.083 | 0.606 | 1.62 | 0.577 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.003 | -0.004 | -0.033 | 0.447 | -0.455 |